Expression of Concern
This article is currently under investigation. We strongly recommend that this article is not cited until the investigation is completed.
This article is currently under investigation. We strongly recommend that this article is not cited until the investigation is completed.
Research Paper Volume 12, Issue 11 pp 10873—10895
miR-137 prevents inflammatory response, oxidative stress, neuronal injury and cognitive impairment via blockade of Src-mediated MAPK signaling pathway in ischemic stroke
Figure 12. miR-137 inhibits Src thus inactivating the MAPK signaling pathway in astrocytes. (A) miR-137 expression and mRNA levels of Src, Erk2, Jnk, p38, Gfap, Bax and Bcl-2 in astrocytes detected using RT-qPCR; (B) protein levels of Src, GFAP, Bax and Bcl-2 along with the extent of ERK1/2, JNK and p38 phosphorylation in astrocytes detected using Western blot analysis. Measurement data are expressed as mean ± standard deviation and compared using one-way ANOVA, followed by Tukey's post hoc test. * p < 0.05 vs. normal astrocytes; # p < 0.05 vs. OGD-induced astrocytes treated with negative controls; & p < 0.05 vs. astrocytes treated with miR-137 inhibitor. The experiment was repeated 3 times independently.